Tuoxin Pharmaceutical Group Co (301089.SZ) Stock Price
Tuoxin Pharmaceutical Group Co Price
Revenue has compounded at 0.1% per year over the past 12 years to 378.34 M CNY. Earnings per share have grown at 29.7% per year over the last 10 years. Tuoxin Pharmaceutical Group Co's net margin stands at -18.4%, down from 13.1% several years earlier. Tuoxin Pharmaceutical Group Co currently offers a dividend yield of about 1.38%. The dividend has grown at 58.1% per year over the past 2 years.
Tuoxin Pharmaceutical Group Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Tuoxin Pharmaceutical Group Co business model & stock analysis
Frequently asked questions about Tuoxin Pharmaceutical Group Co
Converted at the current exchange rate, the Tuoxin Pharmaceutical Group Co share trades at 2.47 EUR (18.13 CNY).
The revenue cannot currently be calculated for Tuoxin Pharmaceutical Group Co.
The profit cannot currently be calculated for Tuoxin Pharmaceutical Group Co.
The P/E ratio cannot be calculated for Tuoxin Pharmaceutical Group Co at the moment.
The P/S cannot be calculated for Tuoxin Pharmaceutical Group Co currently.
The Eulerpool Quality Score for Tuoxin Pharmaceutical Group Co is 2/10.
The ISIN of Tuoxin Pharmaceutical Group Co is CNE100004YC3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Tuoxin Pharmaceutical Group Co is 301089.SZ. The ticker symbol is used to trade Tuoxin Pharmaceutical Group Co shares on the stock exchange.
Tuoxin Pharmaceutical Group Co stock
Tuoxin Pharmaceutical Group Co Peer Group
Tuoxin Pharmaceutical Group Co FIGI
All fundamentals and in-depth analysis of Tuoxin Pharmaceutical Group Co
Our stock analysis for Tuoxin Pharmaceutical Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tuoxin Pharmaceutical Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.